Companies Dominating the Female Stress Urinary Incontinence Treatment Devices Landscape
- Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson Services, Inc.
- Becton, Dickinson and Company
- Coloplast Corp.
- CooperSurgical, Inc.
- MedGyn Products, Inc.
- Caldera Medical, Inc
- FEG Textiltechnik mbH
- Medical Device Business Services, Inc.
- Renovia Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Female Stress Urinary Incontinence Treatment Devices Market in 2025 is estimated at USD 788.2 million.
The global market size was over USD 753.25 million in 2024 and is anticipated to witness a CAGR of around 5.8%, crossing USD 1.57 billion revenue by 2037.
North America is expected to total USD 659.4 million by 2037, driven by well-established healthcare infrastructure, rising R&D investment in drug development, and growing prevalence of SUI.
The major players in the market include Boston Scientific Corporation, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Coloplast Corp., CooperSurgical, Inc., MedGyn Products, Inc., Caldera Medical, Inc, FEG Textiltechnik mbH, Medical Device Business Services, Inc., Renovia Inc.
